O

Oxurion NV
OXUR

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€355.15K
EV
€11.23M
Shares Outstanding
8.50M
Beta
0.57

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Oxurion NV

gainify

O

Oxurion NV

OXUR

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness. It focuses on developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was ...

Sector

Healthcare

Industry

Biotechnology

CEO

Ghoson, Pascal

Employees

11

IPO Date

2006-07-07

Headquarters

Gaston Geenslaan 1, Leuven, Flemish Brabant, 3001, Belgium

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.